跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 160,644 条关于
“THR-123”
全部
160,644
临床试验
154,749
药物
2,326
机构
631
资讯
2,938
去年
DRI Scientists Achieve Diabetes Reversal Using Small Peptide THR-123 in Preclinical Models
2年前
TILT Biotherapeutics Presents Promising Clinical Data on Intravenous TILT-123 at ESMO 2024
去年
Asahi Kasei Pharma Initiates Phase III Trial of ART-123 for Chemotherapy-Induced Peripheral Neuropathy Prevention
去年
TILT Biotherapeutics Advances TILT-123 Immunotherapy with Positive Clinical Trial Data
28天前
CureGene Doses First Participant in Phase I Trial of Oral Liver-Targeting THR-β Agonist CG-0416
3个月前
Kos Biotechnology Partners Closes $123 Million Inaugural Life Sciences Fund, Marking Greece's Largest VC Launch
去年
Insilico Medicine Secures $123 Million Series E Funding to Advance AI-Driven Drug Discovery Pipeline
2年前
FDA Approves Resmetirom (REZDIFFRA™) as First Treatment for NASH
去年
CDSCO Panel Rejects Phase III Trial Waivers for Resmetirom in India, Approves Bioequivalence Studies
去年
Phase 1 Trial Shows Promise for Recurrent Glioblastoma with Targeted Radiopharmaceutical
第 1 页,共 294 页
上一页
下一页